Article Information
History
- April 24, 2021.
Article Versions
- Version 1 (April 22, 2021 - 17:00).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Karen B. Jacobson1,*,
- Benjamin A. Pinsky1,2,
- Maria E. Montez Rath3,
- Hannah Wang, MD2,
- Jacob A. Miller, MD4,
- Mehdi Skhiri5,
- John Shepard6,
- Roshni Mathew7,
- Grace Lee7,
- Bryan Bohman8,
- Julie Parsonnet1,9,† and
- Marisa Holubar1,†
- 1Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA
- 2Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA
- 3Department of Medicine, Division of Nephrology, Stanford University School of Medicine, Stanford, CA, USA
- 4Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA
- 5Department of Medicine, Primary Care and Population Health, Stanford University School of Medicine, Stanford, CA, USA
- 6Department of Quality, Patient Safety and Clinical Effectiveness, Stanford Health Care, Stanford, CA, USA
- 7Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, CA, USA
- 8Workforce Health and Wellness, Stanford University School of Medicine, Stanford, CA, USA
- 9Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA
- ↵*Corresponding author; email: kjacobs{at}stanford.edu
↵† These authors contributed equally
Posted April 24, 2021.
Post-vaccination SARS-CoV-2 infections and incidence of the B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center
